Novel hypoglycemic compounds from wild mushroom Paxillus involutus

Isolation and target identification of antihepatoma polyprenylphenols from the edible mushroom Suillus granulatus

Eight polyprenylphenol derivatives were isolated from the wild edible mushroom Suillus granulatus, including seven novel compounds, named suillin F-L (2-8), and one previously identified compound (1). The structures of the new compounds were elucidated using HR-ESI-MS and 1D and 2D NMR data. The absolute configuration of compound 8 was assigned based on the comparison of the experimental and calculated ECD data. All isolated compounds were evaluated for their cytotoxicity against HepG2 cancer cell lines. Compounds 1 and 3-6 demonstrated significant antitumor activity compared to the positive control (cisplatin), with IC50 values ranging from 8.19 to 13.97 μM. Furthermore, DARTS assay and LC-MS/MS analysis were used to identify HSP90AA1 as the direct target of compound 5, and the interaction between compound 5 and HSP90AA1 was verified by molecular docking.

Biological Activities of Secondary Metabolites from the Edible-Medicinal Macrofungi

Macrofungi are well-known as edible-medicinal mushrooms, which belong mostly to Basidiomycota, with a few from Ascomycota. In recent years, macrofungi have been recognized as a rich resource of structurally unique secondary metabolites, demonstrating a wide range of bioactivities, including anti-tumor, antioxidant, anti-inflammatory, antimicrobial, antimalarial, neuro-protective, hypoglycemic, and hypolipidemic activities. This review highlights over 270 natural products produced by 17 families of macrofungi covering 2017 to 2023, including their structures, bioactivities, and related molecular mechanisms.

Efficient Synthesis and In Vitro Hypoglycemic Activity of Rare Apigenin Glycosylation Derivatives

Apigenin is a natural flavonoid with significant biological activity, but poor solubility in water and low bioavailability limits its use in the food and pharmaceutical industries. In this paper, apigenin-7-O-β-(6″-O)-d-glucoside (AG) and apigenin-7-O-β-(6″-O-succinyl)-d-glucoside (SAG), rare apigenin glycosyl and succinyl derivatives formed by the organic solvent-tolerant bacteria Bacillus licheniformis WNJ02 were used in a 10.0% DMSO (v/v) system. The water solubility of SAG was 174 times that of apigenin, which solved the application problem. In the biotransformation reaction, the conversion rate of apigenin (1.0 g/L) was 100% at 24 h, and the yield of SAG was 94.2%. Molecular docking showed that the hypoglycemic activity of apigenin, apigenin-7-glucosides (AG), and SAG was mediated by binding with amino acids of α-glucosidase. The molecular docking results were verified by an in vitro anti-α-glucosidase assay and glucose consumption assay of active compounds. SAG had significant anti-α-glucosidase activity, with an IC₅₀ of 0.485 mM and enhanced glucose consumption in HepG2 cells, which make it an excellent α-glucosidase inhibitor.

Extraction, Characterization, and In Vitro Hypoglycemic Activity of a Neutral Polysaccharide from the New Medicinal Mushroom Cantharellus yunnanensis (Agaricomycetes)

Polysaccharides serve as promising ingredients for health-beneficial functional foods, while there were no investigations into the structural characterizations and bioactivities of an edible mushroom Cantharellus yunnanensis. In the study, crude polysaccharides from this mushroom were extracted by hot water and isolated by ethanol precipitation. Then, a neutral polysaccharide (named CY-1) was purified from the crude polysaccharide by deproteinization with Sevag reagent, decolorization with a kind of macroporous adsorption resin SP-825, DEAE-52 cellulose column chromatography and dialysis. The physicochemical properties of CY-1 were characterized by UV, IR, SEM, NMR, and HPLC analyses. Structural characterizations revealed that CY-1 is a homogeneous heteropolysaccharide with an average molecular weight of 3.06 × 104 Da. CY-1 exhibited a honeycomb structure with an irregular branching shape, and it was composed of mannose, glucose, fucose, xylose, arabinose, galactose, rhamnose, and glucuronic acid, with molar fractions of 54.83%, 25.11%, 10.28% 4.53%, 2.12%, 1.64%, 0.83%, and 0.64%, respectively. In vitro hypoglycemic tests showed that CY-1 had an inhibitory effect on α-glucosidase. In addition, CY-1 of 160 µg/mL promoted glucose consumption in normal HepG2 cells. These results suggested that CY-1 may be a potential hypoglycemic agent.

First report of Cladobotryumverticillatum (Ascomycota, Hypocreaceae) causing cobweb disease on Paxillusinvolutus

Paxillus, a type of ectomycorrhizal fungi distributed widely in the world, is also an essential category for researching bioactive substances and pharmacological functions. We discovered fruitbodies of Paxillusinvolutus covered in a layer of white mycelium in 2020. Cladobotryumverticillatum, a pathogenic fungus related to cobweb disease, was isolated and identified based on morphological and phylogenetic features. Koch's postulates were used to confirm the pathogenicity. The host range test revealed that C.verticillatum could cause disease in all examined mushrooms except Ganodermasichuanense. To our knowledge, C.verticillatum is a new record species in China and a new pathogen on Paxillusinvolutus.

Edible mushroom industry in China: current state and perspectives

China is one of the largest producers and exporters of wild edible fungi in the world. Cultivation mushroom production value ranks within the top five after grain, vegetable, fruit, and edible oil plantation, greater than sugar, cotton, and tobacco business. More than 40 new varieties of high market value mushrooms from our group were highlighted in this article. Mushroom cultivations have a high impact on China's poverty alleviation program, with earnings at least ten times higher than rice and corn. The products were exported to 137 countries and regions, mainly to Japan, South Korea, ASEAN, the USA, and the European Union, among these, Japan is the biggest import market for cultivated mushrooms from China. Rapid development in the market and an increased demand for edible fungi generally enhance the economy of domestic edible fungi. We are the leading research group in logical farm design that is HACCP-certified to reduce the cost of investment for agriculture, thus broadening the consumption market of edible mushrooms and forming a demand-oriented leading industry for the promotion of human health. The enterprise needs to re-examine the operation plan and the strategic thinking to improve the fundamental drivers based on the available resources of the locality. Mushrooms growing intergrate with upgraded technologies and equipment to become smart agriculture which have smart production and intelligent factories. The purpose of suitable products will not change: delicious, nutritious, healthy, and modern. KEY POINTS: • Cultivation mushroom production value ranks within the top five after grain, vegetable, fruit, and edible oil plantation, greater than sugar, cotton, and tobacco business. • Mushroom cultivations have a high impact on China's poverty alleviation program, with earnings at least ten times higher than rice and corn. • The development of transportation and industrialization of mushrooms facilitate the modernization of mushroom industry in China.